Compound C partially rescued MG-induced cell death (Fig
BMC Psychiatry 20(1):328 Centrum fr epidemiologi och samhllsmedicin
Large-scale randomised controlled trials, including the STEP 1 trial (Wilding et al., NEJM 2021) for semaglutide 2.4 mg, have demonstrated clinically meaningful and sustained weight loss in adults with obesity or overweight with weight-related comorbidities
Regaining lost weight is a possibility when someone goes off the medication, he noted particularly for those who don't have a solid game plan from a lifestyle standpoint
Mild, short-lived reactions can include soreness at the injection site, a brief flushing sensation, mild bruising, or, very rarely, mild nausea
Featured Authors Patricia Ryan, MD The Ohio State University Sonil Patil, MD, MPH Case Western Reserve University Hollie Goodell, RN Ohio University Marilee Clemons, PharmD, BCACP University of Toledo